ABO blood group/ABO kan grubu 23 Acute hepatitis B/Akut hepatit B 108 Anti-HBc/Anti-HBc 34 Anti-HBs/Anti-HBs 6 Anti-HCV/Anti-HCV 6 Anti-hepatitis C virüs/Anti-hepatit C virüsü 65 Anti-human immunodeficiency virus ½/Anti-insan immün yetmezlik virüsü ½ 65 Antiviral treatment/Antiviral tedavi 1 Atypical serology/Atipik seroloji 34 Barbers/Berber 6 Biochemical parameters/Biyokimyasal parametreler 28 Breastfeeding/Emzirme 1 Chronic hepatitis B/Kronik hepatit B 10,23,39,43,52 Chronic hepatitis C/Kronik hepatit C 28,39,58 Circumcision/Sünnet 6 Cirrhosis/Siroz 23,52 Co-infection/Ko-enfeksiyon 39,74 Compensatory mutation/Kompansatuvar mutasyon 103 Complete virological response/Komplet virolojik yanıt 92 Core antigen/Kor antijen 18 Cost/Maliyet 111 Creatment/Tedavi 10 Drug resistance/İlaç direnci 103 Epidemiology/Epidemiyoloji 74 GB virus C/GB virus C 113 Genotype/Genotip 97 Genotype 4/Genotip 4 58 Genotype distribution/Genotip dağılımı 74 HCV RNA titers/HCV RNA titreleri 28 Health care staff/Sağlık çalışanı 62 Hepatitis A/Hepatit A 14 Hepatitis B surface antigen/Hepatit B yüzey antijeni 65 Hepatitis B virus-hepatitis C virus-human immunodeficiency virüs/Hepatit B virüs-hepatit C virüs-insan immün yetmezlik virüs 62 Hepatitis B virus/Hepatit B virüs 1,14,48,6,34,69,82,88,103 Hepatitis C virus/Hepatit C virüs 14,18,48,74,97 Hepatitis G virus/Hepatit G virus 113 Hepatitis/Hepatit 6,111 HIV/HIV 113 Human immunodeficiency virus/İnsan bağışıklık yetmezlik virüsü 39,48 Human pegivirus/İnsan pegivirüs 113 Immunosuppressive therapy/İmmünsüpresif tedavi 69 Interleukin 28B/İnterlökin 28B 97 İstanbul/İstanbul 88 Laboratory personnel/Laboratuvar personeli 82 Liver fibrosis/Karaciğer fibrozisi 23,52 Naive patients/Naif olgular 103 Non-alcoholic fatty liver disease/Alkolik olmayan yağlı karaciğer hastalığı 43 Nucleos(t)ide analogue-experienced/Nükleozit analoğu-deneyimli 92 Nucleos(t)ide analogue-naive/Nükleozit analoğu-naive 92 Occupational risk/Mesleki risk 14 Platelet-derived indices/Trombosit kökenli indeksler 52 Polymorphism/Polimorfizm 97 Pregnancy/Gebelik 10,108 Prevalence/Prevalens 74 Questionnaire/Sorgu formları 82 Reactivation/Reaktivasyon 69 Ribonucleic acid/Ribonükleik asit 18 Risk groups/Risk grupları 65 Schizophrenia/Şizofreni 48 Seroprevalence/Seroprevalans 14,62,65,88 Single nucleotide polymorphisms/Tek nükleotid polimorfizmi 97 Strip immunoblot assay/İmmünblot testi 18 Surface antigen/Hepatit B yüzey antijeni 6 Surveys/Anket 82 Telaprevir/Telaprevir 58 Telbivudine/Telbivudin 10 Tenofovir/Tenofovir 92,108 Transmission/Bulaş 74 Ultrasonograpy/Ultrasonografi 43 Unnecessary test/Gereksiz test 111 Vaccination/Aşılama 82,88
2016 Subject Index
Other
2016 Subject Index
Viral Hepat J 2016;22(3):0-0
Licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND) International License.
CC BY-NC-ND — Attribution-NonCommercial-NoDerivatives 4.0 InternationalThe statements, opinions, and data contained in articles published in this journal are solely those of the individual author(s) and contributor(s) and do not necessarily reflect the views of the journal, its editors, editorial board, owner, or Galenos Publishing House.
Neither the journal nor Galenos Publishing House endorses or recommends any commercial product, process, service, institution, or organization that may be mentioned or advertised in the journal. The publication of advertisements, product information, or links to external websites does not constitute endorsement or approval by the journal or the publisher.
The journal, its editors, editorial board, owner, and Galenos Publishing House make reasonable efforts to ensure the accuracy and integrity of published content; however, they cannot be held responsible for errors, omissions, or any consequences arising from the use of information contained in the journal, to the extent permitted by applicable law.
Information published in the journal is intended for scientific and educational purposes and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Readers should consult appropriately qualified healthcare professionals regarding individual medical conditions or treatment decisions.
External links are provided for informational convenience only. The journal and Galenos Publishing House are not responsible for the availability, accuracy, content, privacy practices, or policies of external websites.
